6533b83afe1ef96bd12a7e84

RESEARCH PRODUCT

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Py KwoEj LawitzJ McconeEr SchiffJm VierlingD PoundMn DavisJs GalatiSc GordonN RavendhranL RossaroFh AndersonIm JacobsonR RubinK KouryLd PediconeCa BrassE ChaudhriJk AlbrechtAntonio Craxi

subject

HCVhttp://hdl.handle.net/10447/73859